{"id":"glycerol","rwe":[],"tags":[],"safety":{"boxedWarnings":[],"safetySignals":[],"drugInteractions":[],"commonSideEffects":[{"effect":"Diarrhea","drugRate":"16%","severity":"common","organSystem":""},{"effect":"Flatulence","drugRate":"14%","severity":"common","organSystem":""},{"effect":"Headache","drugRate":"14%","severity":"common","organSystem":""},{"effect":"Abdominal pain","drugRate":"7%","severity":"common","organSystem":""},{"effect":"Vomiting","drugRate":"7%","severity":"common","organSystem":""},{"effect":"Decreased appetite","drugRate":"7%","severity":"common","organSystem":""},{"effect":"Fatigue","drugRate":"7%","severity":"common","organSystem":""},{"effect":"Dyspepsia","drugRate":"5%","severity":"common","organSystem":""},{"effect":"Nausea","drugRate":"2%","severity":"common","organSystem":""}],"contraindications":[],"specialPopulations":{},"discontinuationRates":[],"seriousAdverseEvents":[]},"trials":[],"_chembl":null,"aliases":["Control infusion","glycerol infusion","Glycerin(e)","glycerol water mixture"],"patents":[],"pricing":[],"offLabel":[],"timeline":[],"_dailymed":{"setId":"900e7dc0-9afe-4f50-80de-90567bb78519","title":"RAVICTI (GLYCEROL PHENYLBUTYRATE) LIQUID [HORIZON THERAPEUTICS USA, INC.]"},"ecosystem":[],"mechanism":{},"_scrapedAt":"2026-03-27T23:31:23.642Z","_scrapedBy":"cloudflare-swarm","_wikipedia":{"url":"https://en.wikipedia.org/wiki/Glycerol","title":"Glycerol","extract":"Glycerol is a sugar alcohol with chemical formula C3H5(OH)3. It has three carbon atoms and as many hydroxyl groups. It is a colorless, odorless, sweet-tasting, viscous liquid at Standard Ambient Temperature and Pressure (SATP). Because of its three hydroxyl groups, glycerol is miscible with water and is hygroscopic in nature."},"references":[],"biosimilars":[],"competitors":[],"dataSources":[{"url":"https://drugcentral.org","name":"DrugCentral","fields":["indications","contraindications","safety","target","drugInteractions"],"retrievedDate":"2026-04-07"}],"indications":{"approved":[{"name":"Constipation","diseaseId":"constipation","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"}],"offLabel":[],"pipeline":[]},"labelChanges":[],"relatedDrugs":[],"trialDetails":[{"nctId":"NCT07495943","phase":"NA","title":"Effects of 2-Aticyto Complex and D-Ribose on Pain and Clinical Course in Patients With Fibromyalgia","status":"NOT_YET_RECRUITING","sponsor":"Haydarpasa Numune Training and Research Hospital","startDate":"2026-05-04","conditions":"Fibromyalgia Syndrome, Fibromyalgia","enrollment":200},{"nctId":"NCT05983588","phase":"PHASE2","title":"PROFIL Study to Investigate the Effect of GPB on NfL Levels in Patients With Corticobasal Syndrome (CBS)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Technical University of Munich","startDate":"2023-12-12","conditions":"Corticobasal Syndrome (CBS)","enrollment":32},{"nctId":"NCT05444439","phase":"NA","title":"Antibiotyping and Prevalence of Virulent Genotypes Among Helicobacter Pylori and Their Impact on Response to Therapy","status":"COMPLETED","sponsor":"Assiut University","startDate":"2024-01-20","conditions":"H Pylori Infection","enrollment":100},{"nctId":"NCT06504160","phase":"PHASE1","title":"Targeted Investigation of Microbiome 2 Treat Atopic Dermatitis (TIME-2)","status":"RECRUITING","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2025-04-10","conditions":"Atopic Dermatitis","enrollment":86},{"nctId":"NCT06795776","phase":"PHASE3","title":"Eschscholzia Study","status":"COMPLETED","sponsor":"A. Vogel AG","startDate":"2025-04-07","conditions":"Sleep","enrollment":104},{"nctId":"NCT05837221","phase":"","title":"Microbiome in Head and Neck Squamous Cell Carcinoma","status":"RECRUITING","sponsor":"University of Colorado, Denver","startDate":"2025-05-23","conditions":"Head and Neck Cancer, Lip Cancer, Oral Cancer","enrollment":60},{"nctId":"NCT07375797","phase":"NA","title":"Fecal Microbiota Transplantation Intervention on Microbiota Composition and Insulin Sensitivity in Diabetes","status":"RECRUITING","sponsor":"Central Jutland Regional Hospital","startDate":"2026-02-05","conditions":"Diabetes Mellitus Type 2, Fecal Microbiota Transplantation (FMT), Oral Glucose Tolerance Test","enrollment":16},{"nctId":"NCT06792500","phase":"PHASE1, PHASE2","title":"A Basket Clinical Study to Assess Glycerol Tributyrate in Patients With Mitochondrial Encephalopathy, Lactic Acidosis, Stroke-like Episodes (MELAS) or Leber's Hereditary Optic Neuropathy-Plus (LHON-Plus)","status":"RECRUITING","sponsor":"George Washington University","startDate":"2026-04","conditions":"MELAS Syndrome, Lebers Hereditory Optic Neuropathy With Extra Ocular Symptoms (LHON-Plus)","enrollment":24},{"nctId":"NCT04614168","phase":"NA","title":"Maximising Time With a Normal Blood Glucose to Restore the Glucagon Response in Type 1 Diabetes","status":"COMPLETED","sponsor":"University of Edinburgh","startDate":"2021-07-26","conditions":"Type 1 Diabetes, Type 1 Diabetes Mellitus With Hypoglycemia, Hypoglycemia","enrollment":24},{"nctId":"NCT07371013","phase":"NA","title":"Fecal Microbiota Transplantation in Children With Autism Spectrum Disorder and Gastrointestinal Symptoms","status":"NOT_YET_RECRUITING","sponsor":"Institute of Mother and Child, Warsaw, Poland","startDate":"2026-01","conditions":"Autism Spectrum Disorder, Gastrointestinal Symptoms","enrollment":20},{"nctId":"NCT07357506","phase":"NA","title":"Reducing Skin Side Effects in Patients Receiving Radiation on Tomotherapy","status":"NOT_YET_RECRUITING","sponsor":"King Faisal Specialist Hospital & Research Center","startDate":"2026-02","conditions":"Head and Neck Cancer","enrollment":104},{"nctId":"NCT04937062","phase":"EARLY_PHASE1","title":"Phenylbutyrate for Monogenetic Developmental and Epileptic Encephalopathy","status":"ACTIVE_NOT_RECRUITING","sponsor":"Weill Medical College of Cornell University","startDate":"2021-03-01","conditions":"STXBP1 Encephalopathy With Epilepsy, SLC6A1 Neurodevelopmental Disorder, Developmental and Epileptic Encephalopathy","enrollment":50},{"nctId":"NCT07053774","phase":"PHASE2","title":"Intranasal and Intravenous Oxytocin for Analgesia to Noxious Heat Pain","status":"RECRUITING","sponsor":"Wake Forest University Health Sciences","startDate":"2025-11-05","conditions":"Pain, Acute","enrollment":24},{"nctId":"NCT06681246","phase":"NA","title":"The Role of Microbiome in Recurrent Obesity Before and After Antibiotic/Placebo Treatment","status":"RECRUITING","sponsor":"Weizmann Institute of Science","startDate":"2024-12-11","conditions":"Obesity, Weight Loss","enrollment":200},{"nctId":"NCT06904027","phase":"","title":"A Clinical Study of Glycerol Phenylbutyrate in Chinese Patients With Urea Cycle Disorders","status":"RECRUITING","sponsor":"Tongji Hospital","startDate":"2025-12-09","conditions":"Urea Cycle Disorders","enrollment":40},{"nctId":"NCT06887777","phase":"PHASE2","title":"Efficacy and Safety of the Treatment of Pyruvate Dehydrogenase Deficiency Patients With Glycerol Phenylbutyrate (RAVICTI)","status":"RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2025-10-01","conditions":"Pyruvate Dehydrogenase Complex Deficiency Disease","enrollment":15},{"nctId":"NCT03420482","phase":"PHASE2","title":"Fecal Microbiota Transplant as Treatment of Hepatic Encephalopathy","status":"ACTIVE_NOT_RECRUITING","sponsor":"Massachusetts General Hospital","startDate":"2018-04-01","conditions":"Hepatic Encephalopathy","enrollment":30},{"nctId":"NCT05182125","phase":"PHASE1","title":"Phase 1 Clinical Trial to Evaluate the Safety and Immunogenicity of HIV-1 Chimp Adenovirus Vaccines Expressing Clade C gp140 & CH505TF gp120 Protein Boost in HIV-uninfected Adult.","status":"COMPLETED","sponsor":"HIV Vaccine Trials Network","startDate":"2021-11-25","conditions":"HIV Infections","enrollment":34},{"nctId":"NCT02408354","phase":"PHASE2","title":"Pilot Study, Comparative, Single-center, Randomized, Crossover, Double-blind, Against Placebo, Testing the Effectiveness of Triheptanoin Oil in Alternating Hemiplegia of Childhood","status":"COMPLETED","sponsor":"Institut National de la Santé Et de la Recherche Médicale, France","startDate":"2015-03-25","conditions":"Alternating Hemiplegia of Childhood","enrollment":10},{"nctId":"NCT04924270","phase":"PHASE2","title":"Safety and Efficacy of Capsule FMT in Treatment-naïve Patients With Newly Diagnosed Chronic Inflammatory Diseases","status":"RECRUITING","sponsor":"Odense University Hospital","startDate":"2023-12-13","conditions":"Rheumatoid Arthritis, Ankylosing Spondylitis, Psoriatic Arthritis","enrollment":200},{"nctId":"NCT07260734","phase":"","title":"AUGMENTED RESPONSE OF VOLATILE BIOMARKERS IN THE ASSESSMENT OF OESOPHAGOGASTRIC CANCER (AROMA2)","status":"NOT_YET_RECRUITING","sponsor":"Imperial College London","startDate":"2025-12-01","conditions":"OESOPHAGO-GASTRIC CARCINOMA, Oesophageal Adenocarcinoma, Gastric Adenocarcinoma and Gastroesophageal Junction Adenocarcinoma","enrollment":6000},{"nctId":"NCT06955130","phase":"NA","title":"Lactate and Glycerol Contribution to Gluconeogenesis","status":"NOT_YET_RECRUITING","sponsor":"Rutgers, The State University of New Jersey","startDate":"2026-07-01","conditions":"Type 2 Diabetes, Obesity, Healthy","enrollment":48},{"nctId":"NCT06981468","phase":"NA","title":"Hydration To be Optimized (H2O) With a Low-sodium Beverage","status":"COMPLETED","sponsor":"Société des Produits Nestlé (SPN)","startDate":"2025-04-16","conditions":"Hydration Status","enrollment":43},{"nctId":"NCT06321536","phase":"PHASE2","title":"Response to Emerging Antimicrobial Resistance With Containment Microbiota Therapy (REACT)","status":"RECRUITING","sponsor":"Emory University","startDate":"2025-01-13","conditions":"Multi-Drug Resistant Organism Colonization","enrollment":60},{"nctId":"NCT07220031","phase":"","title":"Effect of Activated Charcoal on Serum Osmolality, Osmolal Gap, and Enzymatic Ethylene Glycol Assay","status":"NOT_YET_RECRUITING","sponsor":"State University of New York - Upstate Medical University","startDate":"2025-11-15","conditions":"Osmolality Disturbance, Lab Interference","enrollment":8},{"nctId":"NCT01802086","phase":"NA","title":"Emla-Cream as Pain Relief During Pneumococcal Vaccination","status":"COMPLETED","sponsor":"Beatrice Olsson Duse","startDate":"2013-05","conditions":"Children, Pain","enrollment":72},{"nctId":"NCT07217834","phase":"NA","title":"Effects of a Glycerol-Electrolyte Beverage on Fluid Balance in Healthy Euhydrated Men and Women","status":"RECRUITING","sponsor":"PepsiCo Global R&D","startDate":"2025-10-01","conditions":"Fluid Balance","enrollment":30},{"nctId":"NCT05240885","phase":"","title":"Metabolic and Functional Consequences of Aging in Health and Disease","status":"RECRUITING","sponsor":"Texas A&M University","startDate":"2022-03-04","conditions":"Aging","enrollment":100},{"nctId":"NCT02770092","phase":"NA","title":"CHF COPD Sip Feed Anabolic Response","status":"COMPLETED","sponsor":"Texas A&M University","startDate":"2016-02-10","conditions":"Pulmonary Disease, Chronic Obstructive, Congestive Heart Failure","enrollment":90},{"nctId":"NCT02757638","phase":"NA","title":"Omics Profiling of Weight Loss With Bariatric Surgery","status":"COMPLETED","sponsor":"Texas A&M University","startDate":"2016-02-25","conditions":"Obesity, Surgery","enrollment":7},{"nctId":"NCT04041232","phase":"EARLY_PHASE1","title":"PBA Use for Treatment of ATF6-/- Patients","status":"SUSPENDED","sponsor":"Columbia University","startDate":"2025-04-08","conditions":"ACHROMATOPSIA 7, Achromatopsia","enrollment":2},{"nctId":"NCT07140237","phase":"EARLY_PHASE1","title":"The Effect of Oral Oxytocin and Atosiban on Top-down Attention ( OTAtosiban )","status":"RECRUITING","sponsor":"University of Electronic Science and Technology of China","startDate":"2025-09","conditions":"Healthy Adult Male","enrollment":250},{"nctId":"NCT07133854","phase":"NA","title":"How Abnormal Function of Fat Tissue in Type 1 Diabetes Contributes to Fat in the Liver","status":"NOT_YET_RECRUITING","sponsor":"Université de Sherbrooke","startDate":"2026-09","conditions":"Metabolic Dysfunction-Associated Steatotic Liver Disease, Non-Alcoholic Steato-Hepatitis (NASH), Type 1 Diabetes Mellitus","enrollment":32},{"nctId":"NCT04997733","phase":"PHASE3","title":"Fecal Microbiota Transplantation in Crohn's Disease as Relay After Anti-TNF Withdrawal","status":"RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2021-09-22","conditions":"Crohn Disease","enrollment":150},{"nctId":"NCT07093060","phase":"EARLY_PHASE1","title":"The Effect of Oral Oxytocin and Atosiban on Social Attention","status":"RECRUITING","sponsor":"University of Electronic Science and Technology of China","startDate":"2025-06-09","conditions":"Healhty","enrollment":250},{"nctId":"NCT06854471","phase":"NA","title":"Effects of Beverage Volume, Glycerol Concentration, and Sodium Concentration on Fluid Balance in Healthy Euhydrated Men and Women at Rest","status":"RECRUITING","sponsor":"PepsiCo Global R&D","startDate":"2025-04-09","conditions":"Fluid Balance","enrollment":80},{"nctId":"NCT07059988","phase":"NA","title":"Endogenous Energy Production in Critically Ill Patients","status":"NOT_YET_RECRUITING","sponsor":"Karolinska University Hospital","startDate":"2025-07","conditions":"Critical Illness, Metabolism and Nutrition Disorder","enrollment":40},{"nctId":"NCT06491394","phase":"PHASE4","title":"Lactoferrin Effect on Kidney and Heart of Rhabdomyolysis Rats","status":"COMPLETED","sponsor":"Aswan University Hospital","startDate":"2024-11-01","conditions":"Rhabdomyolysis","enrollment":24},{"nctId":"NCT05821309","phase":"PHASE4","title":"Evaluation of Fecal Microbiome Changes After Antegrade Continence Enema Placement and Initiation of Bowel Flush Regimen","status":"RECRUITING","sponsor":"Indiana University","startDate":"2023-06-08","conditions":"Constipation","enrollment":65},{"nctId":"NCT06754670","phase":"","title":"Effect of Hypophosphatemia on Neuro-excursion Efficiency During Mechanical Ventilator Weaning","status":"RECRUITING","sponsor":"Peking Union Medical College","startDate":"2024-10-01","conditions":"Mechanical Ventilation, Weaning Failure, Hypophosphatemia","enrollment":70},{"nctId":"NCT05035342","phase":"PHASE3","title":"Fecal Transplantation to Eradicate Colonizing Emergent Superbugs","status":"RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2024-01-11","conditions":"Enterobacteriaceae Infections, Fecal Microbiota Transplantation","enrollment":214},{"nctId":"NCT06967376","phase":"EARLY_PHASE1","title":"The Role of Adjuvant Corneal Crosslinking in the Management of Infective Keratitis","status":"COMPLETED","sponsor":"Research Institute of Ophthalmology, Egypt","startDate":"2018-05-21","conditions":"Infective Keratitis","enrollment":40},{"nctId":"NCT06350786","phase":"NA","title":"Conditioned Open-label Placebos to Facilitate Opioid Reduction in Patients With Chronic Non-cancer Pain","status":"RECRUITING","sponsor":"Cosima Locher","startDate":"2024-06-12","conditions":"Chronic Non-cancer Pain","enrollment":86},{"nctId":"NCT04450693","phase":"PHASE3","title":"Cryopreserved Human Umbilical Cord (TTAX01) for Late Stage, Complex Non-healing Diabetic Foot Ulcers (AMBULATE DFU II)","status":"COMPLETED","sponsor":"BioTissue Holdings, Inc","startDate":"2020-11-20","conditions":"Diabetic Foot Infection, Non-healing Wound, Non-healing Diabetic Foot Ulcer","enrollment":106},{"nctId":"NCT06286709","phase":"PHASE2","title":"FAecal Microbiota Transplantation in primaRy sclerosinG chOlangitis","status":"RECRUITING","sponsor":"University of Birmingham","startDate":"2024-03-27","conditions":"Primary Sclerosing Cholangitis, Inflammatory Bowel Diseases","enrollment":58},{"nctId":"NCT05480761","phase":"PHASE4","title":"7-Day Trial of Sucraid for Alleviating CSID Symptoms in Subjects With Low, Moderate, and Normal Sucrase Levels","status":"TERMINATED","sponsor":"QOL Medical, LLC","startDate":"2022-08-01","conditions":"Congenital Sucrase-Isomaltase Deficiency, CSID, Sucrase Isomaltase Deficiency","enrollment":312},{"nctId":"NCT04970446","phase":"PHASE1, PHASE2","title":"Microbial Restoration in Inflammatory Bowel Diseases","status":"RECRUITING","sponsor":"St Vincent's Hospital Melbourne","startDate":"2022-05-01","conditions":"Fecal Microbiota Transplantation, Crohn Disease, Inflammatory Bowel Diseases","enrollment":120},{"nctId":"NCT06654557","phase":"NA","title":"Effect of Adding Glycerol to Electrolyte Beverages on Fluid Balance in Healthy Euhydrated Men and Women at Rest","status":"RECRUITING","sponsor":"PepsiCo Global R&D","startDate":"2024-09-30","conditions":"Fluid Balance","enrollment":95},{"nctId":"NCT06818253","phase":"NA","title":"Effect of Glycerol Hyperhydration on Running Economy of Long-distance Runners","status":"COMPLETED","sponsor":"Iberoamerican Institute of Sports Science and Human Movement","startDate":"2022-11-10","conditions":"Running, Physical Conditioning, Human","enrollment":30},{"nctId":"NCT06093997","phase":"NA","title":"Study on the Treatment of C/S of Qi Stagnation and Blood-stasis Type by Moving Cupping with Bloodletting","status":"RECRUITING","sponsor":"Shanghai University of Traditional Chinese Medicine","startDate":"2024-02-28","conditions":"Cervical Spondylosis","enrollment":62},{"nctId":"NCT02780219","phase":"NA","title":"Chronic Obstructive Pulmonary Disorder and Acute Exercise","status":"COMPLETED","sponsor":"Texas A&M University","startDate":"2016-02-04","conditions":"Pulmonary Disease, Chronic Obstructive","enrollment":57},{"nctId":"NCT06801951","phase":"NA","title":"Oral Supplement and Acute Resistance Exercise","status":"COMPLETED","sponsor":"Texas A&M University","startDate":"2017-12-11","conditions":"Chronic Obstructive Pulmonary Disease","enrollment":16},{"nctId":"NCT06801964","phase":"NA","title":"AECOPD and Nutritional Supplementation in COPD","status":"COMPLETED","sponsor":"Texas A&M University","startDate":"2017-10-20","conditions":"Obstructive Pulmonary Disease, Exacerbation Copd","enrollment":5},{"nctId":"NCT03188835","phase":"NA","title":"Effects of Fructose/Glucose-rich Diet on Brown Fat in Healthy Subjects (GB7)","status":"COMPLETED","sponsor":"Université de Sherbrooke","startDate":"2017-05-23","conditions":"Type2 Diabetes","enrollment":15},{"nctId":"NCT04932577","phase":"PHASE2, PHASE3","title":"Faecal Microbiota Transplantation for Liver Cirrhosis","status":"RECRUITING","sponsor":"University of Aarhus","startDate":"2021-07-01","conditions":"Liver Cirrhosis","enrollment":220},{"nctId":"NCT03998488","phase":"PHASE2","title":"Examining the Efficacy of Fecal Microbiota Transplantation (FMT) and Dietary Fiber in Patients With Ulcerative Colitis","status":"COMPLETED","sponsor":"Weill Medical College of Cornell University","startDate":"2020-01-31","conditions":"Ulcerative Colitis, Inflammatory Bowel Diseases","enrollment":27},{"nctId":"NCT06185595","phase":"NA","title":"Effect of Glycerol-Electrolyte Beverages on Fluid Balance in Healthy Euhydrated Men and Women at Rest","status":"COMPLETED","sponsor":"PepsiCo Global R&D","startDate":"2024-01-08","conditions":"Hydration","enrollment":37},{"nctId":"NCT04881461","phase":"PHASE3","title":"A Study in Adults With Grass Pollen-induced Rhinoconjunctivitis","status":"COMPLETED","sponsor":"ALK-Abelló A/S","startDate":"2021-05-10","conditions":"Allergy","enrollment":445},{"nctId":"NCT04749030","phase":"NA","title":"Faecal Microbiota Transplantation for Patients With Diabetes Mellitus Type 1 and Severe Gastrointestinal Neuropathy","status":"COMPLETED","sponsor":"University of Aarhus","startDate":"2021-06-15","conditions":"Faecal Microbiota Transplantation (FMT), Diabetes Mellitus, Type 1, Gastrointestinal Neuropathy","enrollment":20},{"nctId":"NCT05177328","phase":"PHASE1","title":"Targeted Investigation of Microbiome Elimination","status":"TERMINATED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2022-07-18","conditions":"Atopic Dermatitis","enrollment":21},{"nctId":"NCT04300049","phase":"EARLY_PHASE1","title":"Effect of Physiologic Hyperglucogonemia on Adipocyte Metabolism","status":"COMPLETED","sponsor":"The University of Texas Health Science Center at San Antonio","startDate":"2018-02-05","conditions":"Insulin Sensitivity","enrollment":10},{"nctId":"NCT04854291","phase":"NA","title":"A Trial of Fecal Microbiome Transplantation in Parkinson's Disease Patients","status":"COMPLETED","sponsor":"Helsinki University Central Hospital","startDate":"2021-04-25","conditions":"Parkinson Disease","enrollment":51},{"nctId":"NCT03796650","phase":"PHASE3","title":"Fecal Transplantation for Primary Clostridium Difficile Infection","status":"TERMINATED","sponsor":"Oslo University Hospital","startDate":"2019-07-17","conditions":"Clostridium Difficile Infection","enrollment":104},{"nctId":"NCT01257737","phase":"PHASE4","title":"To Evaluate the Safety of Long-term Use of HPN-100 in the Management of Urea Cycle Disorders (UCDs)","status":"COMPLETED","sponsor":"Amgen","startDate":"2010-10-04","conditions":"Urea Cycle Disorders","enrollment":88},{"nctId":"NCT05497934","phase":"PHASE1","title":"The Effects of Glycerol as an Optical Clearing Agent for Visualization of the Middle Ear","status":"WITHDRAWN","sponsor":"Nova Scotia Health Authority","startDate":"2022-10-01","conditions":"Tympanosclerosis, Thickened Ears, Healthy","enrollment":""},{"nctId":"NCT05223816","phase":"PHASE2","title":"An Open-Label, Multiple-Center, Phase IIa/IIb Clinical Trial to Evaluate the Efficacy, Safety and Tolerability of VG161 as Monotherapy and in Combination With Nivolumab for Treatment of Patients With Hepatocellular Carcinoma or Intrahepatic Cholangiocarcinoma","status":"RECRUITING","sponsor":"Virogin Biotech Canada Ltd","startDate":"2024-01-24","conditions":"Hepatocellular Carcinoma, Intrahepatic Cholangiocarcinoma","enrollment":97},{"nctId":"NCT05660447","phase":"PHASE2, PHASE3","title":"A Multi-Center Study on the Use of Rho-Kinase Inhibitor to Reduce or Prevent PVR in RRD Eyes at High Risk for PVR","status":"ACTIVE_NOT_RECRUITING","sponsor":"Wills Eye","startDate":"2023-02-06","conditions":"Rhegmatogenous Retinal Detachment, Proliferative Vitreoretinopathy","enrollment":80},{"nctId":"NCT06502834","phase":"PHASE1","title":"Effect of 4 Weeks of Oral D. Piger on Safety, Pharmacokinetics and Ethanol Metabolism in Overweight Individuals (2023)","status":"RECRUITING","sponsor":"Max Nieuwdorp","startDate":"2024-05-01","conditions":"Obesity, Metabolic Syndrome, Steatosis of Liver","enrollment":20},{"nctId":"NCT01347073","phase":"PHASE3","title":"Study of the Safety, Pharmacokinetics and Efficacy of HPN-100, in Pediatric Subjects With Urea Cycle Disorders (UCDs)","status":"COMPLETED","sponsor":"Amgen","startDate":"2011-07","conditions":"Urea Cycle Disorders","enrollment":23},{"nctId":"NCT00947544","phase":"PHASE2","title":"Study of the Safety and Tolerability of HPN-100 Compared to Sodium Phenylbutyrate in Children With Urea Cycle Disorders","status":"COMPLETED","sponsor":"Amgen","startDate":"2010-03","conditions":"Urea Cycle Disorders","enrollment":17},{"nctId":"NCT00551200","phase":"PHASE2","title":"Dose-Escalation Safety Study of HPN-100 to Treat Urea Cycle Disorders","status":"COMPLETED","sponsor":"Amgen","startDate":"2007-10","conditions":"Urea Cycle Disorders","enrollment":14},{"nctId":"NCT03935139","phase":"NA","title":"Monitoring of the Bone Free Flaps With Microdialysis","status":"RECRUITING","sponsor":"Centre Hospitalier Universitaire, Amiens","startDate":"2019-07-22","conditions":"Flap Necrosis","enrollment":40},{"nctId":"NCT00999167","phase":"PHASE2","title":"A Study of Safety and Efficacy of HPN-100 in Subjects With Cirrhosis and Episodic Hepatic Encephalopathy","status":"COMPLETED","sponsor":"Amgen","startDate":"2009-12","conditions":"Cirrhosis, Hepatic Encephalopathy","enrollment":189},{"nctId":"NCT00947297","phase":"PHASE3","title":"Study of the Safety of HPN (Hyperion)-100 for the Long-Term Treatment of Urea Cycle Disorders (Treat UCD)","status":"COMPLETED","sponsor":"Amgen","startDate":"2009-11","conditions":"Urea Cycle Disorders","enrollment":60},{"nctId":"NCT00992459","phase":"PHASE3","title":"Efficacy and Safety of HPN-100 for the Treatment of Adults With Urea Cycle Disorders","status":"COMPLETED","sponsor":"Amgen","startDate":"2009-10","conditions":"Urea Cycle Disorders","enrollment":46},{"nctId":"NCT05329636","phase":"PHASE1, PHASE2","title":"Auto Fecal Microbial Transplant Post Helicobacter Pylori Antibiotic Therapy","status":"RECRUITING","sponsor":"Tel-Aviv Sourasky Medical Center","startDate":"2018-09-26","conditions":"Helicobacter Pylori Infection","enrollment":30},{"nctId":"NCT01948427","phase":"","title":"Observational Study That Will Collect Information on Patients With Urea Cycle Disorders (UCDs)","status":"TERMINATED","sponsor":"Amgen","startDate":"2013-09-25","conditions":"Urea Cycle Disorder","enrollment":203},{"nctId":"NCT02246218","phase":"PHASE4","title":"A Study of the Safety, Efficacy and Pharmacokinetics of Glycerol Phenylbutyrate in Pediatric Subjects Under 2 Years of Age With Urea Cycle Disorders","status":"COMPLETED","sponsor":"Amgen","startDate":"2014-12-31","conditions":"Urea Cycle Disorder","enrollment":27},{"nctId":"NCT03335488","phase":"PHASE4","title":"Study of Glycerol Phenylbutyrate & Sodium Phenylbutyrate in Phenylbutyrate Naïve Patients With Urea Cycle Disorders (UCDs)","status":"COMPLETED","sponsor":"Amgen","startDate":"2018-02-20","conditions":"Urea Cycle Disorder","enrollment":16},{"nctId":"NCT05432089","phase":"PHASE2","title":"The Effects of Oxytocin Administration to Patients and Therapists on Physiological Synchronization","status":"RECRUITING","sponsor":"Shalvata Mental Health Center","startDate":"2023-03-30","conditions":"Severe Mental Illness","enrollment":120},{"nctId":"NCT03566069","phase":"PHASE2","title":"Intranasal Oxytocin as Enhancer of Psychotherapy Outcomes in Severe Mental Illness","status":"ACTIVE_NOT_RECRUITING","sponsor":"Shalvata Mental Health Center","startDate":"2018-06-01","conditions":"Severe Mental Illness","enrollment":120},{"nctId":"NCT00986895","phase":"PHASE1","title":"A Study of Glyceryl Tri-(4-phenylbutyrate) Administered Orally as a Single Dose, and Twice Daily for Seven Consecutive Days to Subjects With Hepatic Impairment With Cirrhosis and to a Control Group","status":"COMPLETED","sponsor":"Amgen","startDate":"2006-09","conditions":"Hepatic Encephalopathy, Urea Cycle Disorders","enrollment":32},{"nctId":"NCT01135680","phase":"PHASE1","title":"Double-Blind Randomized Crossover Trial to Access Electrocardiogram Effects of HPN-100","status":"COMPLETED","sponsor":"Amgen","startDate":"2010-05","conditions":"Drug Toxicity","enrollment":98},{"nctId":"NCT00977600","phase":"PHASE1","title":"A Study of Glyceryl Tri-(4-phenylbutyrate) (GT4P)","status":"COMPLETED","sponsor":"Amgen","startDate":"2005-03","conditions":"Healthy","enrollment":24},{"nctId":"NCT04176120","phase":"PHASE3","title":"Cryopreserved Human Umbilical Cord (TTAX01) for Late Stage, Complex Non-healing Diabetic Foot Ulcers (AMBULATE DFU)","status":"COMPLETED","sponsor":"BioTissue Holdings, Inc","startDate":"2020-07-01","conditions":"Diabetic Foot Infection, Non-healing Wound, Non-healing Diabetic Foot Ulcer","enrollment":220},{"nctId":"NCT06451588","phase":"PHASE2","title":"Fecal Microbiota Transplantation in Axial Spondyloarthritis","status":"RECRUITING","sponsor":"University Hospital of North Norway","startDate":"2024-06-01","conditions":"Axial Spondyloarthritis, Ankylosing Spondylitis, Dysbiosis","enrollment":99},{"nctId":"NCT05882188","phase":"NA","title":"The Cost-effectiveness of Hysterosalpingography Versus Hysterosalpingo-foam Sonography During Fertility Work-up","status":"RECRUITING","sponsor":"Amsterdam UMC, location VUmc","startDate":"2023-09-22","conditions":"Infertility","enrollment":1102},{"nctId":"NCT06358911","phase":"PHASE4","title":"A Clinical Study for the Effect of 4th Generation Poly AmidoAmine Dendrimer on Post-Bleaching Hypersensitivity and Shade Stability","status":"COMPLETED","sponsor":"Ain Shams University","startDate":"2021-11-13","conditions":"Tooth Hypersensitivity","enrollment":60},{"nctId":"NCT05129488","phase":"NA","title":"Biotrue ONEday Contact Lenses With EPG03 Packaging Solution Compared to Biotrue ONEday Contact Lenses","status":"COMPLETED","sponsor":"Bausch & Lomb Incorporated","startDate":"2021-09-15","conditions":"Contact Lens Wearer","enrollment":33},{"nctId":"NCT05780801","phase":"PHASE1","title":"Sentinel Cohort REACT","status":"COMPLETED","sponsor":"Emory University","startDate":"2023-04-24","conditions":"Multi-Drug Resistant Organism","enrollment":10},{"nctId":"NCT06332066","phase":"PHASE1","title":"Oxytocin Administration to Therapists and Its Effects on Patient-perceived Attunement and Responsiveness","status":"NOT_YET_RECRUITING","sponsor":"Shalvata Mental Health Center","startDate":"2024-05-01","conditions":"Mental Health Therapists","enrollment":20},{"nctId":"NCT06313307","phase":"NA","title":"The Efficacy in Treatment of Facial Melasma Combined With Thulium 1927-nm Fractional Laser and Topical H2R Antagonist","status":"COMPLETED","sponsor":"Second Affiliated Hospital of Xi'an Jiaotong University","startDate":"2023-04-01","conditions":"Melasma","enrollment":16},{"nctId":"NCT05430178","phase":"NA","title":"Metabolic Pathology of Pediatric NAFLD","status":"RECRUITING","sponsor":"University of Oklahoma","startDate":"2022-05-25","conditions":"Nonalcoholic Fatty Liver, Nonalcoholic Steatohepatitis, Obesity","enrollment":100},{"nctId":"NCT02862249","phase":"PHASE3","title":"Trial of Faecal Microbiota Transplantation in Cirrhosis","status":"COMPLETED","sponsor":"King's College London","startDate":"2018-03-27","conditions":"Cirrhosis of the Liver","enrollment":32},{"nctId":"NCT04968951","phase":"EARLY_PHASE1","title":"Refined Fecal Microbiota Transplantation (FMT) for Ulcerative Colitis (UC)","status":"TERMINATED","sponsor":"Ari M Grinspan","startDate":"2021-11-10","conditions":"Ulcerative Colitis, FMT, Fecal Microbiota Transplant","enrollment":4},{"nctId":"NCT03691987","phase":"PHASE2","title":"The Comeback Study","status":"COMPLETED","sponsor":"University Hospital of North Norway","startDate":"2019-02-15","conditions":"Chronic Fatigue Syndrome, Myalgic Encephalomyelitis","enrollment":80},{"nctId":"NCT04146909","phase":"NA","title":"The Effect of Lactation on Insulin Sensitivity and Lipolysis in Women","status":"TERMINATED","sponsor":"Yale University","startDate":"2020-11-17","conditions":"GDM, Lactation","enrollment":7},{"nctId":"NCT02517307","phase":"NA","title":"Fatty Acid Oxidation Defects and Insulin Sensitivity","status":"COMPLETED","sponsor":"Oregon Health and Science University","startDate":"2016-02","conditions":"Very Long-chain Acyl-CoA Dehydrogenase Deficiency, Trifunctional Protein Deficiency, Long-chain 3-hydroxyacyl-CoA Dehydrogenase Deficiency","enrollment":41},{"nctId":"NCT05093530","phase":"PHASE1","title":"Safety and Tolerability of Single and Multiple Doses of Neumifil","status":"COMPLETED","sponsor":"Pneumagen Ltd.","startDate":"2021-10-12","conditions":"Viral Respiratory Tract Infection","enrollment":60},{"nctId":"NCT03915613","phase":"PHASE1, PHASE2","title":"Brain Insulin Resistance in Mood Disorders","status":"UNKNOWN","sponsor":"University Health Network, Toronto","startDate":"2021-10-06","conditions":"Major Depressive Disorder, Bipolar Disorder, Anhedonia","enrollment":150}],"_emaApprovals":[],"_faersSignals":[{"count":158,"reaction":"CONSTIPATION"},{"count":142,"reaction":"FALL"},{"count":125,"reaction":"PAIN"},{"count":123,"reaction":"HYPOTENSION"},{"count":116,"reaction":"ORTHOSTATIC HYPOTENSION"},{"count":107,"reaction":"BLOOD CALCIUM DECREASED"},{"count":106,"reaction":"BALANCE DISORDER"},{"count":105,"reaction":"COGNITIVE DISORDER"},{"count":104,"reaction":"CREATININE RENAL CLEARANCE DECREASED"},{"count":102,"reaction":"MOBILITY DECREASED"}],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"administration":{},"formularyStatus":[],"_approvalHistory":[{"date":"20211202","type":"ORIG","sponsor":"PH HEALTH","applicationNumber":"ANDA205742"},{"date":"20191004","type":"SUPPL","sponsor":"HORIZON THERAP US","applicationNumber":"NDA203284"},{"date":"20160908","type":"SUPPL","sponsor":"HORIZON THERAP US","applicationNumber":"NDA203284"},{"date":"20130201","type":"ORIG","sponsor":"HORIZON THERAP US","applicationNumber":"NDA203284"},{"date":"20150105","type":"SUPPL","sponsor":"HORIZON THERAP US","applicationNumber":"NDA203284"},{"date":"20210903","type":"SUPPL","sponsor":"HORIZON THERAP US","applicationNumber":"NDA203284"},{"date":"20181221","type":"SUPPL","sponsor":"HORIZON THERAP US","applicationNumber":"NDA203284"},{"date":"20170428","type":"SUPPL","sponsor":"HORIZON THERAP US","applicationNumber":"NDA203284"},{"date":"20150727","type":"SUPPL","sponsor":"HORIZON THERAP US","applicationNumber":"NDA203284"},{"date":"20140624","type":"SUPPL","sponsor":"HORIZON THERAP US","applicationNumber":"NDA203284"}],"developmentCodes":[],"ownershipHistory":[],"publicationCount":59831,"therapeuticAreas":["Metabolic"],"biosimilarFilings":[],"companionDiagnostics":[],"genericManufacturerList":[],"phase":"marketed","status":"active","brandName":"Glycerol","genericName":"Glycerol","companyName":"Rutgers, The State University of New Jersey","companyId":"rutgers-the-state-university-of-new-jersey","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":1,"regulatoryByCountry":[{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":3,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":false,"indications":true,"safety":true,"trials":true,"score":3}}